Comparison of Two New Generation Dressings in Intensive Care (ADVANCED)

Comparison Between Two Types of Semipermeable Dressings of New Generation in the Prevention of Intravascular Catheters Related Complications in Intensive Care.

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01773564

Acronym

ADVANCED

Enrollment

628

Registered

2013-01-23

Start date

2012-10-31

Completion date

2013-10-31

Last updated

2016-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complication of Catheter

Keywords

Dressings, Prevention,

Brief summary

Intravascular devices in intensive care units are often associated to complications. The investigators estimate that 23.5% of catheters placed and used in intensive care are subject to at least one complication; the investigators goal is to demonstrate the effectiveness of the new Tegaderm ™ IV Advanced dressings to achieve a decrease of 35% in the number of complications associated with intravascular catheters in intensive care.

Detailed description

randomized controlled trial of 2 intravascular dressings in Intensive care unit

Interventions

DEVICECurrent hospital dressing

Patients were assigned to either arm following a randomization scheme 1:1.

DEVICE3M™ IV Advanced Securement dressing

Patients were assigned to either arm following a randomization scheme 1:1.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients over 18 years with a central venous catheter, an arterial catheter, a hemodialysis catheter, a Swan Ganz catheter or a peripheral catheter inserted in the ICU or within the 24 before their arrival at the ICU in another ICU setting. * Patients benefiting from the social security protection.

Exclusion criteria

* Patients under 18 years of age, * Patients having known allergy or sensitivity to adhesive dressing materials

Design outcomes

Primary

Measure	Time frame
Number of catheters presenting any kind of complications..	From the insertion of the catheter to its removal, an average time frame thant can go up to 4 weeks.

Secondary

Measure	Time frame
Number of catheter infections related to poor adherent dressings.	From the insertion of the catheter to its removal, an average time frame thant can go up to 4 weeks

Other

Measure	Time frame
Number of participants presenting allergic adverse events	From the insertion of the catheter to its removal, an average time frame thant can go up to 4 weeks.
Costs of each dressing type strategy.	From the insertion of the catheter to its removal, an average time frame thant can go up to 4 weeks.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026